2024 HCPCS Code C9097
Inj, faricimab-svoa, 0.1 mg
Notice | HCPCS C9097 terminated on September 30, 2022. |
Short Description | Inj, faricimab-svoa, 0.1 mg |
HCPCS Coverage Code | C - Carrier judgment |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Action Effective Date | October 01, 2022 |
HCPCS Code Added Date | July 01, 2022 |
HCPCS Pricing Indicator Code | 53 - Statute |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | 1 - Medical care |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- C9475 - Injection, necitumumab
- C9476 - Injection, daratumumab
- C9477 - Injection, elotuzumab
- C9478 - Injection, sebelipase alfa
- C9479 - Instill, ciprofloxacin otic
- C9480 - Injection, trabectedin
- C9481 - Injection, reslizumab
- C9482 - Sotalol hydrochloride iv
- C9483 - Injection, atezolizumab
- C9484 - Injection, eteplirsen
- C9485 - Injection, olaratumab
- C9486 - Inj, granisetron ext
- C9487 - Ustekinumab iv inj, 1 mg
- C9488 - Conivaptan hcl
- C9489 - Injection, nusinersen
- C9490 - Injection, bezlotoxumab
- C9491 - Injection, avelumab
- C9492 - Injection, durvalumab
- C9493 - Injection, edaravone
- C9494 - Injection, ocrelizumab